Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

References for PMC Articles for PubMed (Select 19308688)

1.

CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.

Vallacchi V, Daniotti M, Ratti F, Di Stasi D, Deho P, De Filippo A, Tragni G, Balsari A, Carbone A, Rivoltini L, Parmiani G, Lazar N, Perbal B, Rodolfo M.

Cancer Res. 2008 Feb 1;68(3):715-23. doi: 10.1158/0008-5472.CAN-07-2103. Erratum in: Cancer Res. 2008 Mar 15;68(6):2051.

2.

A "class action" against the microenvironment: do cancer cells cooperate in metastasis?

Bidard FC, Pierga JY, Vincent-Salomon A, Poupon MF.

Cancer Metastasis Rev. 2008 Mar;27(1):5-10. Review.

3.

Osteopontin: regulation in tumor metastasis.

Wai PY, Kuo PC.

Cancer Metastasis Rev. 2008 Mar;27(1):103-18. Review.

PMID:
18049863
4.

Osteopontin as a molecular prognostic marker for melanoma.

Rangel J, Nosrati M, Torabian S, Shaikh L, Leong SP, Haqq C, Miller JR 3rd, Sagebiel RW, Kashani-Sabet M.

Cancer. 2008 Jan 1;112(1):144-50.

5.

Downregulation of CCN3 expression as a potential mechanism for melanoma progression.

Fukunaga-Kalabis M, Martinez G, Telson SM, Liu ZJ, Balint K, Juhasz I, Elder DE, Perbal B, Herlyn M.

Oncogene. 2008 Apr 17;27(18):2552-60. Epub 2007 Oct 29.

PMID:
17968313
6.
7.

SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth.

Prada F, Benedetti LG, Bravo AI, Alvarez MJ, Carbone C, Podhajcer OL.

J Invest Dermatol. 2007 Nov;127(11):2618-28. Epub 2007 Jul 12.

8.

A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.

Alonso SR, Tracey L, Ortiz P, Pérez-Gómez B, Palacios J, Pollán M, Linares J, Serrano S, Sáez-Castillo AI, Sánchez L, Pajares R, Sánchez-Aguilera A, Artiga MJ, Piris MA, Rodríguez-Peralto JL.

Cancer Res. 2007 Apr 1;67(7):3450-60.

9.

Molecular mechanism of tenascin-C action on matrix metalloproteinase-1 invasive potential.

Galoian KA, Garamszegi N, Garamszegi SP, Scully SP.

Exp Biol Med (Maywood). 2007 Apr;232(4):515-22.

PMID:
17392487
10.

Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.

Hayashi C, Rittling S, Hayata T, Amagasa T, Denhardt D, Ezura Y, Nakashima K, Noda M.

J Cell Biochem. 2007 Jul 1;101(4):979-86.

PMID:
17390343
11.

Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.

Bleau AM, Planque N, Lazar N, Zambelli D, Ori A, Quan T, Fisher G, Scotlandi K, Perbal B.

J Cell Biochem. 2007 Aug 15;101(6):1475-91.

PMID:
17340618
12.

Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.

Javelaud D, Mohammad KS, McKenna CR, Fournier P, Luciani F, Niewolna M, André J, Delmas V, Larue L, Guise TA, Mauviel A.

Cancer Res. 2007 Mar 1;67(5):2317-24.

13.

Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12.

Sarkar S, Nuttall RK, Liu S, Edwards DR, Yong VW.

Cancer Res. 2006 Dec 15;66(24):11771-80.

14.

The Src signaling pathway: a potential target in melanoma and other malignancies.

Homsi J, Cubitt C, Daud A.

Expert Opin Ther Targets. 2007 Jan;11(1):91-100. Review.

PMID:
17150037
15.

CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.

Fukunaga-Kalabis M, Martinez G, Liu ZJ, Kalabis J, Mrass P, Weninger W, Firth SM, Planque N, Perbal B, Herlyn M.

J Cell Biol. 2006 Nov 20;175(4):563-9. Epub 2006 Nov 13.

16.

Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion.

Kääriäinen E, Nummela P, Soikkeli J, Yin M, Lukk M, Jahkola T, Virolainen S, Ora A, Ukkonen E, Saksela O, Hölttä E.

J Pathol. 2006 Oct;210(2):181-91.

PMID:
16924594
17.

SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.

Robert G, Gaggioli C, Bailet O, Chavey C, Abbe P, Aberdam E, Sabatié E, Cano A, Garcia de Herreros A, Ballotti R, Tartare-Deckert S.

Cancer Res. 2006 Aug 1;66(15):7516-23.

18.

A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation.

McCallum L, Price S, Planque N, Perbal B, Pierce A, Whetton AD, Irvine AE.

Blood. 2006 Sep 1;108(5):1716-23. Epub 2006 May 2.

19.

Normal stem cells and cancer stem cells: the niche matters.

Li L, Neaves WB.

Cancer Res. 2006 May 1;66(9):4553-7. Review. Erratum in: Cancer Res. 2006 Jun 15;66(12):6458.

20.

Tenascin-C induced signaling in cancer.

Orend G, Chiquet-Ehrismann R.

Cancer Lett. 2006 Dec 8;244(2):143-63. Epub 2006 Apr 24. Review.

PMID:
16632194
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk